findmyKOL

Joseph Chacko, MD

Basic profile

University of Arkansas for Medical Sciences

ORCIDNone on fileNPI
RegionLittle Rock, AR · South CentralSpecialtyOphthalmologyFocusOphthalmology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Joseph Chacko is an Ophthalmology physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 51 publications with 508 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
51publications

Distinct works indexed by OpenAlex.

508citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    58.5%
    Prostaglandin Analog27.8%
    Latanoprost100%
    Part D32 patients
    Carbonic Anhydrase Inhibitor19.3%
    Acetazolamide51%Dorzolamide-Timolol18%Acetazolamide Er17%Dorzolamide Hcl14%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    18.2%
    Corticosteroid15.4%
    Prednisone100%
    Part D30 patients
    H2 blocker2.8%
    Famotidine100%
    Part D<11 patients
  • Nervous system

    14.9%
    Cholinesterase Inhibitor9.1%
    Pyridostigmine Bromide100%
    Part D17 patients
    Gabapentinoids5.8%
    Gabapentin100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”